Yuji Iwashita

8PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsNatural hazards
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 08, 2024
The spectrum of TP53 mutations in Rwandan patients with gastric cancer.

Augustin Nzitakera, Jean Bosco Surwumwe, Ella Larissa Ndoricyimpaye

|Nov 24, 2023
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung Cancer.

De Hu, Hidetaka Yamada, Katsuhiro Yoshimura

|Jun 30, 2023
TP53 mutations in Romanian patients with colorectal cancer.

Felix Manirakiza, Hidetaka Yamada, Yuji Iwashita

|May 26, 2023
Clinicopathological Characteristics and Mutational Landscape of APC, HOXB13, and KRAS among Rwandan Patients with Colorectal Cancer.

Felix Manirakiza, Eric Rutaganda, Hidetaka Yamada

|Dec 02, 2021
A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2'-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients.

Yuto Matsushita, Yuji Iwashita, Shunsuke Ohtsuka

Pageof 2